INNT
TOTAL INVALIDATION PROCESSED BY THE IB
08/22/2025
Back to search
Official data from USPTO
POLYPHOR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
POLYPHOR
ST13
US500000079212487Class
1, 5, 42
Filing
79212487
Registration
5393654
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
08/23/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
03/10/2017
Registration date
02/06/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/23/2024
Last transaction
08/23/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
DANG, PETER
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Polyphor AG
Representatives
Scott D. Woldow Smith, Gambrell, Russell, LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industryscienceagriculturehorticulture and silvicultureexcept fungicidesherbicidesinsecticides and parasiticides; unprocessed artificial resinsunprocessed plastics; soil fertilizers; chemical substances for preserving foodstuffsfood preservatives; adhesives used in industry
Class 5
Pharmaceuticalveterinary and sanitary productsPharmaceutical anti-allergic preparations and substancesPharmaceutical for the treatment of erectile dysfunctionPharmaceutical preparationsanticoagulantsPharmaceutical preparationsantidepressantsPharmaceutical preparationsappetite suppressantsPharmaceutical preparations for use in chemotherapyPharmaceutical preparation for the treatment of goutPharmaceutical preparations for the treatment of heart rhythm disordersPharmaceutical preparations for the treatment of stem cell mobilizationPharmaceutical preparations for the treatment of infectious diseasesPharmaceutical preparations acting on the central nervous systemPharmaceutical preparations and substances for the treatment of gastro-intestinal diseasesPharmaceutical preparations for animal skincarePharmaceutical preparations for inhalation for the treatment of pulmonary hypertensionPharmaceutical preparations for ocular or intraocular surgeryPharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosisPharmaceutical preparations for treating allergic rhinitis and asthmaPharmaceutical preparations for treating diabetesPharmaceutical preparations for treating skin disordersPharmaceutical preparations for use in dermatologyPharmaceutical preparations for woundsPharmaceutical preparations for use in urologyPharmaceutical preparationsa blood clotting aid and delivery system for use in human and veterinary medicinePharmaceutical products and preparations against dry skin caused by pregnancyPharmaceutical products and preparations for chloasmaPharmaceutical products and preparations for hydrating the skin during pregnancyPharmaceutical products and preparations for pregnancy blemishesPharmaceutical products and preparations for preventing skin blemishes during pregnancyPharmaceutical products and preparations to prevent stretch marksPharmaceutical products and preparations to prevent swelling in the legsPharmaceutical products for ophthalmological usePharmaceutical products for skin care for animalsPharmaceutical products for the treatment of bone diseasesPharmaceutical products for the treatment of viral and infectious diseases and for the treatment of cancerPharmaceutical products for treating respiratory diseases and asthmaPharmaceutical skin lotionsPharmaceutical solutions used in dialysisPharmaceuticalsantihelminticsPharmaceuticalsinducers of erectionsPharmaceuticalslipid lowering agentsPharmaceuticalspsychotropicsPharmaceuticalsanti-infectives; Veterinary preparationspain relief medicationveterinary preparations for the treatment of intestinal bacteriaVeterinary vaccine for horsesVeterinary vaccines; sanitary preparations for medical purposes; disinfectants; products for destroying verminvermin destroying preparations; fungicidesherbicides
Class 42
Researchconsultancyproduct development based on internal and customer data in the field chemistry regarding chemicals and resins; Planning of information technology systems for others based on internal and customer data in the field chemistry for researching chemicals and resins
Publications
History of USPTO decisions and trademark events.
35 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/07/2025
INPC
INVALIDATION PROCESSED
08/06/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
04/23/2025
C71T
CANCELLED SECTION 71
08/23/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/06/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/29/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/07/2022
RNWL
INTERNATIONAL REGISTRATION RENEWED
01/24/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/19/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/22/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/14/2018
FIMP
FINAL DISPOSITION PROCESSED
05/14/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/06/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
02/06/2018
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
01/22/2018
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/24/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/21/2017
PUBO
PUBLISHED FOR OPPOSITION
11/21/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/01/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/02/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/22/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/22/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/22/2017
RFNT
REFUSAL PROCESSED BY IB
08/11/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/27/2017
RFRR
REFUSAL PROCESSED BY MPU
07/27/2017
MAFR
APPLICATION FILING RECEIPT MAILED
07/25/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/21/2017
CNRT
NON-FINAL ACTION WRITTEN
07/20/2017
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/19/2017
DOCK
ASSIGNED TO EXAMINER
07/19/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/19/2017
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/14/2017
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
07/13/2017
Continuous trademark protection
Get notified about every new filing that threatens POLYPHOR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.